Leerink Swann Upgrades Regeneron Pharma (REGN) to Outperform; Shares Back to Decent Levels
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $803.48 -0.31%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Swann upgraded Regeneron Pharma (NASDAQ: REGN) from Market Perform to Outperform.
Leerink analyst says, "REGN shares continue to be volatile, returning to the levels where we first initiated after reaching the $70s when infections were reported with off-label Avastin. With the 2nd year of VIEW data around the corner representing a significant binary event, we believe current levels offer a decent entry point on a risk-adjusted basis."
"We estimate 50% upside if Eylea beats by >1.5 injections (15% probability); 25% upside if Eylea beats by 0.5-1.5 injections (45% probability); 20% downside if Eylea is as good as Lucentis (30% probability) and 35% downside if Eylea is worse than Lucentis (10% probability)."
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $57.09 yesterday.
Leerink analyst says, "REGN shares continue to be volatile, returning to the levels where we first initiated after reaching the $70s when infections were reported with off-label Avastin. With the 2nd year of VIEW data around the corner representing a significant binary event, we believe current levels offer a decent entry point on a risk-adjusted basis."
"We estimate 50% upside if Eylea beats by >1.5 injections (15% probability); 25% upside if Eylea beats by 0.5-1.5 injections (45% probability); 20% downside if Eylea is as good as Lucentis (30% probability) and 35% downside if Eylea is worse than Lucentis (10% probability)."
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $57.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
- TD Cowen Upgrades Northland Power Inc. (NPI:CN) (NPIFF) to Buy
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
